Diabetes Induced by Immune Checkpoint Inhibitors (ICIs)

被引：1

作者：

Verges, Bruno ^{[1
,2
]}

机构：

[1] Med Univ, Univ Hosp, Endocrinol Diabetol Dept, F-21000 Dijon, France

[2] Med Univ, INSERM, CRI866, F-21000 Dijon, France

来源：

关键词：

diabetes; Immune Check point Inhibitors; anti-PD-1; anti PD-L1;

D O I：

10.1016/j.ando.2023.03.012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：351 / 351

页数：1

共 5 条

[1] Fulminant type 1 diabetes - A nationwide survey in Japan
Imagawa, A
Hanafusa, T
Uchigata, Y
Kanatsuka, A
Kawasaki, E
Kobayashi, T
Shimada, A
Shimizu, I
Toyoda, T
Maruyama, T
Makino, H
[J]. DIABETES CARE, 2003, 26 (08) : 2345 - 2352
[2] Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature
Lo Preiato, V.
Salvagni, S.
Ricci, C.
Ardizzoni, A.
Pagotto, U.
Pelusi, C.
[J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (02) : 337 - 349
[3] Tachibana Megumi, 2022, Best Pract Res Clin Endocrinol Metab, V36, P101657, DOI 10.1016/j.beem.2022.101657
[4] Takada Shinya, 2020, Asian Pac J Cancer Prev, V21, P1697, DOI 10.31557/APJCP.2020.21.6.1697
[5] Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials A Systematic Review and Meta-analysis
Wang, Yucai
Zhou, Shouhao
Yang, Fang
Qi, Xinyue
Wang, Xin
Guan, Xiaoxiang
Shen, Chan
Duma, Narjust
Aguilera, Jesus Vera
Chintakuntlawar, Ashish
Price, Katharine A.
Molina, Julian R.
Pagliaro, Lance C.
Halfdanarson, Thorvardur R.
Grothey, Axel
Markovic, Svetomir N.
Nowakowski, Grzegorz S.
Ansel, Stephen M.
Wang, Michael L.
[J]. JAMA ONCOLOGY, 2019, 5 (07) : 1008 - 1019